A Greek fertility clinic is heading to trial on allegations that include the use of sham embryos and the trafficking of women, according to The Australian. The case represents one of the most serious sets of charges ever brought against a fertility clinic in Europe.
This one is worth sitting with. The allegations, sham embryos and trafficked women inside a licensed clinic, are a reminder that accreditation alone does not equal trustworthiness. If you are working with a clinic abroad, your attorney and agency should be able to explain exactly how that clinic is vetted.
A judge in the UK has issued a public warning against unlawful commercial surrogacy arrangements, according to The Law Society Gazette. The warning signals that courts are paying close attention to how surrogacy agreements are structured, particularly where payment beyond reasonable expenses may be involved.
If you are pursuing a cross-border arrangement that involves the UK, the structure of any payments in your agreement deserves a close look with a solicitor before you proceed, not after.
ABC7 Los Angeles spoke exclusively with an attorney connected to the Arcadia case involving Guojun Xuan, who is at the center of a surrogacy scandal involving attempts to father 21 children through American surrogates. The interview offers new insight into the motivations behind the arrangement, which has drawn scrutiny from law enforcement and the surrogacy community alike.
This case keeps adding detail. It is the clearest recent example of how agency screening, not just legal agreements, is the first line of defense for surrogates.
A new market report projects the IVF clinic insurance market will reach $6.68 billion by 2030, growing at a compound annual growth rate of 8.3%, according to EIN News. The figures reflect accelerating demand for fertility services and the financial products being built around them.
A market this size attracts serious investment, which generally means more product options for families. It also means more complexity when comparing policies. Worth keeping an eye on as coverage options evolve.
The thread connecting today's news is institutional accountability: a Greek clinic heading to trial for alleged fraud, a UK judge issuing a direct public warning about unlawful commercial arrangements, and the Arcadia case generating new exclusive reporting on the motivations of the man at its center. Each story, in a different way, involves a licensed or established structure that allegedly failed to protect the most vulnerable people inside it. That pattern is worth naming plainly.
Know ThisHow Surrogate Compensation Actually Works
Surrogate compensation is structured in two distinct layers: a base pay amount and a collection of allowances that together make up the total package. The base pay is a fixed sum paid to the surrogate over the course of the pregnancy, typically disbursed in monthly installments once a confirmed heartbeat is established. Allowances, on the other hand, cover specific circumstances and milestones — things like the embryo transfer procedure, bed rest if it is medically required, invasive medical procedures such as a cesarean section, and the loss of reproductive organs in a worst-case scenario. Each of these carries its own set dollar amount spelled out in the legal contract before the journey begins.
Reimbursable expenses are separate from both of these categories. They generally include maternity clothing, travel to and from medical appointments, childcare or housekeeping needed because of pregnancy-related limitations, and lost wages if the surrogate must miss work for medical reasons. These reimbursements are paid as the expenses occur rather than on a set schedule.
All compensation and reimbursements flow through a neutral third-party escrow account, sometimes called a trust account, managed by a professional administrator. Intended parents fund this account in advance, and disbursements are released according to the timeline written into the contract — giving both parties a transparent, documented record of every payment.
On the tax side, the IRS has not issued definitive guidance specifically for surrogacy income, and outcomes can vary based on individual circumstances. Most surrogates are advised to consult a tax professional, as some portions of compensation may be considered taxable income while reimbursements tied to direct expenses typically are not.
Because allowances and reimbursements stack on top of the base rate, the total amount a surrogate receives by the end of her journey is often meaningfully higher than the single number advertised at the start of the matching process.
Get this brief in your inbox every morning.
One email, the stories that matter for your journey, explained.